Terminal
Stocks
Spotlight
News

Stocks
Healthcare
NASDAQ
ALNY

Market Cap: $28.92B

AI

Alnylam Pharmaceuticals, Inc.

ALNY

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

Cashu

Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Cashu Markets Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin79.72%

EBITDA Margin23.95%

EBIT Margin22.81%

Pre-tax Margin16.64%

Net Profit Margin16.82%

Earnings Yield2.65%

Valuation Multiples

Price / Book22.51

Price / Sales6.37

Price / Earnings37.50

PEG0.01

Forward PEG0.79

EV / Sales6.28

EV / EBITDA26.22

EV / Operating Cash Flow47.54

EV / Free Cash Flow55.60

Price / Free Cash Flow56.41

Price / Operating Cash Flow48.03

Cash Flow & Capital

Free Cash Flow / Share$4.07

Operating Cash Flow / Share$4.76

Free Cash Flow Yield1.77%

Capex / Revenue1.91%

Capex / Operating Cash Flow14.49%

Capex / Depreciation1.68

Stock Compensation / Revenue7.01%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio3.05

Quick Ratio2.99

Cash Ratio1.13

Debt / Assets0.23

Debt / Capital0.48

Debt / Equity0.94

Long-Term Debt / Capital0.43

Debt / Market Cap3.30%

Net Debt / EBITDA-0.38

Solvency Ratio0.21

Financial Leverage4.11

Efficiency & Working Capital

Asset Turnover0.86

Fixed Asset Turnover6.51

Inventory Turnover10.03

Receivables Turnover5.26

Payables Turnover9.02

Days Sales Outstanding69.35

Days Inventory Outstanding36.38

Days Payables Outstanding40.46

Operating Cycle105.72

Cash Conversion Cycle65.26

Working Capital Turnover1.61

Returns & Quality

Return on Equity93.61%

Return on Assets14.54%

Return on Invested Capital24.43%

ROCE24.71%

Return on Tangible Assets14.54%

Operating Return on Assets18.71%

Income Quality0.79

Tax Burden1.01

Interest Burden0.73

Balance Sheet & Intrinsic Metrics

Enterprise Value$30.16B

Invested Capital$3.85B

Working Capital$3.11B

Tangible Asset Value$1.35B

Net Current Asset Value$415.52M

Graham Number$37.24

Graham Net-Net-$1.23

Book Value / Share$10.16

Tangible Book Value / Share$10.16

Cash / Share$24.83

Financial Health Scores

Piotroski Score6

Altman Z-Score4.80

Revenue$4.8B

EBIT$1.1B

Market Cap$29.48B

Working Capital$3.11B

Retained Earnings$-6.33B

Total Assets$5.56B

Total Liabilities$4.2B